The French National Authority for Health limits the use of the Oxford-AstraZeneca vaccine to those aged over 55 years old after it was discovered that three patients who suffered blood clots are younger than 55 years old. (The New York Times) COVID-19 pandemic in FranceCOVID-19 pandemic in EuropeCOVID-19 pandemic link embed save